| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.0062 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0007 | 1 |